申请人:Kolczewski Sabine
公开号:US20100197715A1
公开(公告)日:2010-08-05
The present invention relates to a compound of formula I
wherein R
1
, R
2
, and Ar are as defined herein or to a pharmaceutically acceptable acid addition salt, to a racemic mixture, or to its corresponding enantiomer and/or optical isomer thereof. These compounds and their pharmaceutical compositions are useful in the treatment of neurological and neuropsychiatric disorders.
本发明涉及式I的化合物,其中R1、R2和Ar定义如本文中所述,或涉及一种药物可接受的酸性加成盐,或涉及其相应的对映体和/或光学异构体。这些化合物及其药物组合物可用于治疗神经和神经精神障碍。